DK2082225T3 - Fremgangsmåde til bestemmelse af, om en tumorcelle har invasivt og/eller metastatisk potentiale, og midler tilmodulering af malign transformation - Google Patents

Fremgangsmåde til bestemmelse af, om en tumorcelle har invasivt og/eller metastatisk potentiale, og midler tilmodulering af malign transformation

Info

Publication number
DK2082225T3
DK2082225T3 DK07823920.9T DK07823920T DK2082225T3 DK 2082225 T3 DK2082225 T3 DK 2082225T3 DK 07823920 T DK07823920 T DK 07823920T DK 2082225 T3 DK2082225 T3 DK 2082225T3
Authority
DK
Denmark
Prior art keywords
invasive
determining whether
tumor cell
metastatic potential
malignant transformation
Prior art date
Application number
DK07823920.9T
Other languages
English (en)
Inventor
Mohamed K El-Tanani
Patrick Gerard Johnston
Original Assignee
Univ Belfast
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0618486.5A external-priority patent/GB0618486D0/en
Priority claimed from GB0625379A external-priority patent/GB0625379D0/en
Application filed by Univ Belfast filed Critical Univ Belfast
Application granted granted Critical
Publication of DK2082225T3 publication Critical patent/DK2082225T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/11Antisense
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/14Type of nucleic acid interfering nucleic acids [NA]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK07823920.9T 2006-09-20 2007-09-20 Fremgangsmåde til bestemmelse af, om en tumorcelle har invasivt og/eller metastatisk potentiale, og midler tilmodulering af malign transformation DK2082225T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0618486.5A GB0618486D0 (en) 2006-09-20 2006-09-20 Assay
GB0625379A GB0625379D0 (en) 2006-12-20 2006-12-20 Assay
PCT/GB2007/003599 WO2008035096A1 (en) 2006-09-20 2007-09-20 Assay

Publications (1)

Publication Number Publication Date
DK2082225T3 true DK2082225T3 (da) 2014-04-07

Family

ID=38988374

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07823920.9T DK2082225T3 (da) 2006-09-20 2007-09-20 Fremgangsmåde til bestemmelse af, om en tumorcelle har invasivt og/eller metastatisk potentiale, og midler tilmodulering af malign transformation

Country Status (7)

Country Link
US (1) US8609332B2 (da)
EP (1) EP2082225B1 (da)
DK (1) DK2082225T3 (da)
ES (1) ES2453374T3 (da)
PL (1) PL2082225T3 (da)
PT (1) PT2082225E (da)
WO (1) WO2008035096A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2904960A1 (en) 2013-03-14 2014-10-02 University Of Florida Research Foundation, Inc. Di-amino acid repeat-containing proteins associated with als
US10509045B2 (en) 2015-05-29 2019-12-17 University Of Florida Research Foundation, Incorporated Methods for diagnosing Huntington's disease
US10940161B2 (en) 2016-04-04 2021-03-09 University Of Florida Research Foundation, Incorporated Manipulation of EIF3 to modulate repeat associated non-ATG (RAN) translation
CA3060250A1 (en) 2017-04-17 2018-10-25 University Of Florida Research Foundation, Incorporated Regulation of ran protein translation by pkr and eif2a-p pathways
US12504380B2 (en) * 2017-09-25 2025-12-23 University Of Florida Research Foundation, Incorporated Immunoassays for detection of ran proteins
JP7350337B2 (ja) 2017-09-26 2023-09-26 ユニバーシティー オブ フロリダ リサーチ ファンデーション, インク. 神経障害の処置においてranタンパク質レベルを低下させるためのメトホルミンおよびそのアナログの使用
WO2021055880A1 (en) 2019-09-20 2021-03-25 University Of Florida Researchfoundation, Incorporated Detection of antibodies against ran proteins from serum and tissue lysates
GB201915598D0 (en) * 2019-10-28 2019-12-11 Univ Bradford Methods for determining the invasive and/or metastic potential of a tumour

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613534B2 (en) * 2001-03-20 2003-09-02 Wake Forest University Health Sciences MAP-2 as a determinant of metastatic potential
US20040219572A1 (en) 2002-12-17 2004-11-04 Jie Chen Specific markers for pancreatic cancer
EP1677733A4 (en) 2003-10-03 2007-09-19 Bayer Pharmaceuticals Corp GENE EXPRESSION PROFILES AND METHOD OF USE
US7521195B1 (en) * 2005-07-21 2009-04-21 Celera Corporation Lung disease targets and uses thereof

Also Published As

Publication number Publication date
EP2082225A1 (en) 2009-07-29
EP2082225B1 (en) 2014-01-01
PT2082225E (pt) 2014-04-10
WO2008035096A1 (en) 2008-03-27
US20090312395A1 (en) 2009-12-17
US8609332B2 (en) 2013-12-17
PL2082225T3 (pl) 2014-06-30
ES2453374T3 (es) 2014-04-07

Similar Documents

Publication Publication Date Title
DK3185012T3 (da) Fremgangsmåde til identificering, udvælgelse og analyse af tumorceller
DK2233943T3 (da) System til tilvejebringelse af positionsinformation, indendørs transmitter samt fremgangsmåde til tilvejebringelse af positionsinformation
DK2167963T3 (da) Polymerbærere til immunhistokemi og in situ-hybridisering
BRPI0716944A2 (pt) biomarcadores de modulaÇço alvo, eficÁcia, diagnàstico, e/ou prognàstico para inibidores de raf
DK2342220T3 (da) Metoder og systemer til forudsigelse af misfoldede proteinepitoper
DK2634955T3 (da) Fremgangsmåde til informationsautentifikation og informationsautentifikationssystem
DK2271933T3 (da) System og fremgangsmåde til cellekarakterisering
EP2269086A4 (en) SYSTEM AND METHOD FOR POSITIONING, DETECTION AND COMMUNICATION
DK1974058T3 (da) Genekspressionsmarkører til prognosticering af kolorektal cancer
BRPI0819734A2 (pt) sistema para autenticação de uma marca compreendendo uma pluralidade de marcadores, método para autenticação de uma pluralidade de marcadores, e método para aplicação de uma pluralidade de marcadores a um substrato.
EA201890925A2 (ru) Способы и аппараты для прогнозирования риска рака предстательной железы и объема предстательной железы
DK2214471T3 (da) Fremgangsmåde og system til opvarmning og affugtning
NL2003118A1 (nl) Alignment system, lithographic system and method.
BRPI0720695A2 (pt) Compostos e métodos para modulação de cinase, e indicações para estes
BRPI0922309A2 (pt) método, meio legível por computador, e, aparelho.
DK2134663T3 (da) Beskyttelseslag på højtemperaturudholdende chromoxiddannende substrater, og fremgangsmåde til fremstilling deraf
DK3339321T3 (da) Modulatorer af myc, fremgangsmåder til anvendelse af samme og fremgangsmåder til at identificere stoffer der modulerer myc
DK2212640T3 (da) Integreret ventilatordrivsystem til køletårn og fremgangsmåde ti l drift af vådkøletårn
DK3106875T3 (da) Fremgangsmåde til detektering af cancer
DK2600655T3 (da) Systeminformationsopdateringer i LTE
IL201890A0 (en) System, method and device for comprehensive individualized genetic information or genetic counseling
NL2003543A1 (nl) Multiple simultaneous frequency detection.
DK2622765T3 (da) Systemer, fremgangsmåder og apparater til bestemmelse af styrefelt- og modulations-kodnings-schemeinformationer
FI20075874L (fi) Menetelmä, järjestelmä ja laitteet tiedon keräämiseksi
NO20083908L (no) Fluidanalysesystem og metode for drift av et analysesystem